Trit Garg, M.D.
Trit Garg, M.D. is a Deal Professional Principal at Patient Square Capital. Prior to joining Patient Square, Dr. Garg was a Principal at HealthQuest Capital, where he focused on investment opportunities across health care and life sciences. Previously, Dr. Garg was a resident physician in Internal Medicine at Stanford University Hospital. Earlier during his medical training, he worked on KKR’s Americas Health Care Team and at McKinsey & Company.
Dr. Garg currently serves on the boards of directors of Access TeleCare, Ambros Therapeutics, Kriya Therapeutics, Enavate Sciences, and Osanni Bio. He previously served on the boards of directors of Elevage Medical Technologies and Patterson Companies.
Dr. Garg holds an M.D. from Stanford Medical School, an M.B.A. from Stanford’s Graduate School of Business, and a B.A. with high distinction from the University of California, Berkeley.